Do advers health effects of chrysotile and amphibole asbestos differ?;Gibt es Unterschiede in den gesundheitsschädlichen Wirkungen von Chrysotil- und Amphibol-Asbest?

Pneumologie

Volumn 66, Issue 8, 2012, Pages 497-506

  Baur, X ^a   Schneider, J ^b   Woitowitz, H J ^a   Velasco Garrido, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBOLE; ASBESTOS; ASBESTOS FIBER; CHRYSOTILE;

ARTICLE; ASBESTOSIS; CARCINOGENICITY; COMPARATIVE STUDY; HEALTH HAZARD; HUMAN; IN VITRO STUDY; LUNG CANCER; MESOTHELIOMA; NONHUMAN; OCCUPATIONAL HAZARD; PLEURAL FIBROSIS; PRIORITY JOURNAL;

ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; ASBESTOSIS; EVIDENCE-BASED MEDICINE; HUMANS; LITERATURE BASED DISCOVERY; LUNG NEOPLASMS; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84864724118     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0032-1309980     Document Type: Article

References (112)

1. Baur X, Clasen M, Fisseler-Eckhoff A et al. Diagnostics and expert opinion of asbestos-induced occupational diseases. Pneumologie: 2011; 65 1 47
2. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol: 2003; 15 1247 1274 (Pubitemid 37474836)
3. Jones JS, Smith PG, Pooley FD et al. The consequences of exposure to asbestos dust in a wartime gas-mask factory. IARC Sci Publ: 1980; 637 653
4. McDonald AD, McDonald JC, Pooley FD. Mineral fibre content of lung in mesothelial tumours in North America. Ann Occup Hyg: 1982; 26 417 422 (Pubitemid 13232245)
5. Pooley FD. An examination of the fibrous mineral content of asbestos lung tissue from the Canadian chrysotile mining industry. Environ Res: 1976; 12 281 298 (Pubitemid 8010291)
6. Woitowitz HJ, Manke J, Brückel B et al. Asbestkörperchen als Beweismittel einer beruflichen Gefährdung durch Weißasbest (Chrysotil)? Zbl Arbeitsmed: 1986; 36 354 364 (Pubitemid 17219117)
7. Wagner JC, Moncrief CB, Coles R et al. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med: 1986; 43 391 395 (Pubitemid 16059231)
8. Sebastien P, Begin R. Alveolar clearance of chrysotile in the sheep model - preliminary observations. In: VI International Pneumoconiosis Conference. Bremerhaven Wirtschaftsverlag NW: 1983; 1010 1020
9. Weller W, Kißler W, Friedrichs KH. Fibrogenität ultramikroskopischer Asbest-Fasern. In: VI International Pneumoconiosis Conference. Bremerhaven Wirtschaftsverlag NW: 1983; 1021 1027
10. Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal Toxicol: 2005; 17 1 14 (Pubitemid 40053613)
11. Rödelsperger K, Woitowitz HJ. Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos. Ann Occup Hyg: 1995; 39 715 725
12. Heitz P. Neue Definitionen der Minimalasbestose. Dtsch Ärztebl: 1997; 94 A975
13. Institut für Pathologie der Ruhr-Universität Bochum Deutsches Mesotheliomsregister. http://www.bergmannsheil.de/56.0html
14. Müller K-M. Deutsches Mesotheliomregister. BPUVZ: 2005; 691
15. Wiethege T. Differentialdiagnose bösartiger Pleuratumoren - Immunhistochemische und molekularbiologische Untersuchungsbefunde - Inaugural-Dissertation. Deutsches Mesotheliomregister Universität Essen: Zentrum für Pathologie und Rechtsmedizin, Institut für Pathologie: 2000; http://duepublico.uni-duisburg-essen.de/servlets/DerivateServlet/Derivate- 10463/Wiethege%20-%20Differentialdiagnose%20b%C3%B6sartiger%20Pleuratumoren.pdf
16. Pohlmann J. Immunhistochemische Differentialdiagnose von kleinzelligen Lungenkarzinomen und epitheloiden Mesotheliomen. Inaugural-Dissertation. Hohe Medizinische Fakultät der Ruhr-Universität-Bochum: 2007; http://www-brs.ub.ruhr-uni-bochum.de/netahtml/HSS/Diss/PohlmannJanine/diss.pdf
17. Kanzlei Battenstein & Battenstein Mesotheliomregister. 2011; http://www.battenstein.com/blog/tag/mesotheliomregister/
18. Clasen M. Stellungnahme des Bundesverbandes der Asbestose Selbsthilfegruppen. In: Falkensteiner Tage 2010 Kolloquium zur Begutachtung asbestbedingter Berufskrankheiten. Berlin DGUV: 2011; 129 133
19. Deutsche Gesetzliche Unfallversicherung Spitzenverband der landwirtschaftlichen Sozialversicherung. Empfehlung für die Begutachtung asbestbedingter Berufskrankheiten - Falkensteiner Empfehlung. Berlin DGUV: 2011
20. Neumann V, Theile A, Loseke S et al. Neue Aspekte zur Pathogenese der Asbestose. Arbeitsmed Sozialmed Umweltmed: 2011; 46 569 579
21. McDonald JC, McDonald AD. Chrysotile, tremolite and carcinogenicity. Ann Occup Hyg: 1997; 41 699 705
22. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health: 1996; 86 179 186 (Pubitemid 26055211)
23. Editorial. Asbestos scandal. Nature: 2010; 468 868
24. Canadian Environmental Law Association Stephen Harper's killer legacy. 2010; http://www.cela.ca/newsevents/advertisement/stephen-harpers-killer-legacy
25. Schneider J, Rödelsperger K. Staub und Staubinhaltsstoffe/Asbest. In: Wichmann HE, Schlipköter HW, Fülgraff G. eds. Handbuch der Umweltmedizin Toxikologie, Epidemiologie, Hygiene, Belastungen, Wirkungen, Diagnostik, Prophylaxe. Landsberg ecomed: 1998; 2 37
26. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe der DFG Asbest-Feinstaub und asbesthaltiger Feinstaub. Zur Frage von Unterschieden in der gesundheitsschädlichen Wirkung der Asbestarten Chrysotil, Amosit und Krokydolith Nachtrag 1981. In: Hartwig A. ed. Gesundheitsschädliche Arbeitsstoffe Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten (Maximale Arbeitsplatzkonzentrationen). Weinheim WILEY-VCH: 1981
27. IARC Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). In: IARC Working group on the evaluation of carcinogenic risks to humans ed. A review of human carcinogens. Part C: Arsenic, metals, fibres, and dusts. Lyon IARC: 2009; 219 310 http://monographs.iarc.fr/ENG/ Monographs/vol100C/mono100C-11.pdf
28. WHO, IARC Asbestos (Chrysotile, Amosite, Crocidolite, Tremolite, Actinolite and Anthophyllite). A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts Lyon WHO, IARC: 2012
29. WHO, IARC eds. Overall evaluations of carcinogenicity: An updating of IARC Monographs volumes 1 to 42. Supplement 7. Lyon IARC: 1987; http://monographs.iarc.fr/ENG/Monographs/suppl7/suppl7.pdf
30. Berman DW, Crump KS. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol: 2008; 38 49 73
31. Lenters V, Vermeulen R, Dogger S et al. A Meta-Analysis of Asbestos and Lung Cancer: Is Better Quality Exposure Assessment Associated with Steeper Slopes of the Exposure-Response Relationships? Environ Health Perspect: 2011
32. Deng Q, Wang X, Wang M et al. Exposure-response relationship between chrysotile exposure and mortality from lung cancer and asbestosis. Occup Environ Med: 2012; 69 81 86
33. Wang X, Yano E, Qiu H et al. A 37-year observation of mortality in Chinese chrysotile asbestos workers. Thorax: 2012; 67 106 110
34. Wang X, Lin S, Yano E et al. Mortality in a Chinese chrysotile miner cohort. Int Arch Occup Environ Health: 2011
35. Elliott L, Loomis D, Dement J et al. Lung cancer mortality in North Carolina and South Carolina chrysotile asbestos textile workers. Occup Environ Med: 2012; 69 385 390
36. Hein MJ, Stayner LT, Lehman E et al. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med: 2007; 64 616 625 (Pubitemid 47345257)
37. Loomis D, Dement JM, Wolf SH et al. Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Occup Environ Med: 2009; 66 535 542
38. Liddell FD, McDonald AD, McDonald JC. The 1891-1920 birth cohort of Quebec chrysotile miners and millers: development from 1904 and mortality to 1992. Ann Occup Hyg: 1997; 41 13 36 (Pubitemid 27092316)
39. Pira E, Pelucchi C, Piolatto PG et al. Mortality from cancer and other causes in the Balangero cohort of chrysotile asbestos miners. Occup Environ Med: 2009; 66 805 809
40. McDonald AD, Fry JS, Woolley AJ et al. Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med: 1984; 41 151 157 (Pubitemid 14093271)
41. Sullivan PA. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect: 2007; 115 579 585 (Pubitemid 46585530)
42. Berry G, de Klerk NH, Reid A et al. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med: 2004; 61 14
43. Levin JL, McLarty JW, Hurst GA et al. Tyler asbestos workers: mortality experience in a cohort exposed to amosite. Occup Environ Med: 1998; 55 155 160 (Pubitemid 28212194)
44. Seidman H, Selikoff IJ, Gelb SK. Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short-term work exposure. Am J Ind Med: 1986; 10 479 514 (Pubitemid 17226417)
45. IPCS ed. Asbestos and other natural mineral fibres. Geneva WHO: 1986
46. WHO Air quality guidelines for Europe. 2nd ed. Copenhagen WHO: 2000
47. WHO, IARC Some inorganic and organometallic compounds. Summary of data reported and evaluation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Lyon IARC: 1998; 2 http://monographs.iarc.fr/ENG/Monographs/vol2/ volume2.pdf
48. IARC ed. Asbestos. Summary of data reported and evaluation Lyon: 1998
49. Schneider J, Woitowitz HJ. Pleuramesotheliom. In: Wichmann HE, Schlipköter HW, Füllgraff G. eds. Handbuch der Umweltmedizin Toxikologie, Epidemiologie, Hygiene, Belastungen, Wirkungen, Diagnostik, Prophylaxe. Landsberg ecomed: 1995; 1 20
50. Piolatto G, Negri E, La Vecchia C et al. An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med: 1990; 47 810 814
51. Hodgson JT, Darnton A. Mesothelioma risk from chrysotile. Occup Environ Med: 2010; 67 432
52. Kanarek MS. Mesothelioma from chrysotile asbestos: update. Ann Epidemiol: 2011; 21 688 697
53. Dumortier P, Rey F, Viallat JR et al. Chrysotile and tremolite asbestos fibres in the lungs and parietal pleura of Corsican goats. Occup Environ Med: 2002; 59 643 646 (Pubitemid 34983593)
54. Mitchev K, Dumortier P, De Vuyst P. Black Spots' and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol: 2002; 26 1198 1206 (Pubitemid 34969189)
55. Bundesministerium für Arbeit und Sozialordnung Merkblatt zur BK Nr. 4104: Lungenkrebs oder Kehlkopfkrebs in Verbindung mit Asbeststaublungenerkrankung (Asbestose), in Verbindung mit durch Asbeststaub verursachter Erkrankung der Pleura oder bei Nachweis der Einwirkung einer kumulativen Asbestfaserstaub-Dosis am Arbeitsplatz von mindestens 25 Faserjahren (25×106 [(Fasern/m3)×Jahre]). Bek. des BMA v. 1.12.1997- IVa 4-45206. BArbBl: 1997; 32 35
56. Pira E, Pelucchi C, Buffoni L et al. Cancer mortality in a cohort of asbestos textile workers. Br J Cancer: 2005; 92 580 586 (Pubitemid 40395542)
57. Institute of Medicine of the National Academies ed. Asbestos. Selected cancers. Committee on Asbestos: Selected Health Effects. Board on Population Health and Public Health Practices. Washington, D. C The National Academies: 2006
58. Straif K, Benbrahim-Tallaa L, Baan R et al. A review of human carcinogens - part C: metals, arsenic, dusts, and fibres. Lancet Oncol: 2009; 10 453 454
59. Camargo MC, Stayner LT, Straif K et al. Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect: 2011; 119 1211 1217
60. Mossman BT, Bignon J. Asbestos: scientific developments and implications for public policy. Science: 1990; 247 4940 294 301 (Pubitemid 20046453)
61. U.S. Department of Health and Human Services Toxicological profile for asbestos. Atlanta, Georgia U.S. Department of Health and Human Services Public Health Service Agency for Toxic Substances and Disease Registry: 2001; 441
62. Musk AW, de Klerk NH, Reid A et al. Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom. Occup Environ Med: 2008; 65 541 543
63. Woitowitz H-J, Schäcke G, Woitowitz R. Zu den Auswirkungen von Pleuraverkalkungen bei Chrysotil-Asbestarbeitern auf die Lungenfunktion. Med Welt: 1971; 22 931 935
64. Broaddus VC, Everitt JI, Black B et al. Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J Toxicol Environ Health B Crit Rev: 2011; 14 153 178
65. Ameille J, Rosenberg N, Matrat M et al. Asbestos-related diseases in automobile mechanics. Ann Occup Hyg: 2012; 56 55 60
66. Liddell D. Cancer mortality in chrysotile mining and milling: exposure-response. Ann Occup Hyg: 1994; 38 519 523 412 (Pubitemid 24274605)
67. Becklake MR, Liddell FD, Manfreda J et al. Radiological changes after withdrawal from asbestos exposure. Br J Ind Med: 1979; 36 23 28 (Pubitemid 9121914)
68. Rubino GF, Newhouse M, Murray R et al. Radiologic changes after cessation of exposure among chrysotile asbestos miners in Italy. Ann N Y Acad Sci: 1979; 330 157 161 (Pubitemid 11223558)
69. Berry G, Gilson JC, Holmes S et al. Asbestosis: a study of dose-response relationships in an asbestos textile factory. Br J Ind Med: 1979; 36 98 112 (Pubitemid 9200387)
70. Viallat JR, Boutin C, Pietri JF et al. Late progression of radiographic changes in Canari chrysotile mine and mill exworkers. Arch Environ Health: 1983; 38 54 58 (Pubitemid 13115157)
71. WHO ed. International Programme on Chemical Safety (IPCS). Chrysotile asbestos Geneva: 1998
72. Baur X, Wilken D. Effect of asbestos fibre dust exposures on lung function - a systematic review. Pneumologie: 2010; 64 81 110
73. Wilken D, Velasco Garrido M, Manuwald U et al. Lung function in asbestos-exposed workers, a systematic review and meta-analysis. J Occup Med Toxicol: 2011; 6 21
74. Risk Assessment Information System (RAIS) ed. Toxicity summary for asbestos. Oak Ridge Chemical Hazard Evaluation and Communication Group, Biomedical and Environmental Information Analysis Section. Health and Safety Research Division: 1995
75. Roller M. Bedeutung von In-vitro-Methoden zur Beurteilung der chronischen Toxizität und Karzinogenität von Nanomaterialien, Feinstäuben und Fasern. Dortmund, Berlin BAuA: 2011; 1 365
76. Roller M, Akkan Z, Hassauer M, Kalberlah F. Risikoextrapolation vom Versuchstier auf den Menschen bei Kanzerogenen - Forschung Fb 1078. Bremerhaven BAuA. Wirtschaftsverlag NW: 2006
77. WHO ed. International Programme on Chemical Safety (IPCS). Asbestos and other natural mineral fibres Geneva: 1986
78. Pott F, Roller M, Althoff GH et al. Beurteilung der Kanzerogenität von inhalierbaren Fasern. In: Kommission Reinhaltung der Luft im VDI und DIN Faserförmige Stäube Vorschriften Wirkungen Messung Minderung Tagung Fulda, 7-9 September 1993. Düsseldorf VDI-Verlag: 1993; 17 77
79. Pott F, Roller M, Ziem U et al. Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. In: Bignon J, Peto J, Saracci R. eds. Non-occupational Exposure to Mineral Fibres. Lyon International Agency for Research on Cancer: 1989; 173 179
80. Davis JM, Jones AD. Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol: 1988; 69 717 737
81. Davis JM, Beckett ST, Bolton RE et al. Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer: 1978; 37 673 688 (Pubitemid 8344888)
82. Davis JM, Beckett ST, Bolton RE et al. The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats. Br J Exp Pathol: 1980; 61 272 280 (Pubitemid 10003512)
83. Davis JM, Addison J, Bolton RE et al. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol: 1986; 67 415 430 (Pubitemid 16059890)
84. Davis JM, Bolton RE, Douglas AN et al. Effects of electrostatic charge on the pathogenicity of chrysotile asbestos. Br J Ind Med: 1988; 45 292 299
85. Pott F, Ziem U, Reiffer FJ et al. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp Pathol: 1987; 32 129 152
86. Pott F, Dungworth DL, Heinrich U et al. Lung tumours in rats after intratracheal instillation of dusts. Ann Occup Hyg: 1994; 38 357 363
87. Davis JM, Bolton RE, Miller BG et al. Mesothelioma dose response following intraperitoneal injection of mineral fibres. Int J Exp Pathol: 1991; 72 263 274
88. Pott F, Roller M. Die krebserzeigende Wirkung von Fasern unter besonderer Berücksichtigung der Inhalationsversuche. Dortmund Bundesanstalt für Arbeitsschutz: 1993
89. Davis JM, Addison J, Bolton RE et al. Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis: 1985; 6 667 674 (Pubitemid 15064163)
90. Davis JM, Addison J, Bolton RE et al. Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Br J Exp Pathol: 1986; 67 113 129 (Pubitemid 16050601)
91. Davis JM, Beckett ST, Bolton RE et al. A comparison of the pathological effects in rats of the UICC reference samples of amosite and chrysotile with those of amosite and chrysotile collected from the factory environment. IARC Sci Publ: 1980; 285 292
92. Wagner JC, Berry G, Skidmore JW et al. The effects of the inhalation of asbestos in rats. Br J Cancer: 1974; 29 252 269
93. Wagner JC, Griffiths DM, Hill RJ. The effect of fibre size on the in vivo activity of UICC crocidolite. Br J Cancer: 1984; 49 453 458 (Pubitemid 14125253)
94. Pott F, Roller M, Althoff GH. Krebsrisiko durch Fasern - ein zusammenfassender Vergleich von epidemiologischen und tierexperimentellen Daten. In: Gesellschaft zur Förderung der Lufthygiene und Silikoseforschung e.V Umwelthygiene. 27. Jahresbericht 1994/95. Düsseldorf Medizinisches Institut für Umwelthygiene: 1995; 133 200
95. Mast RW, McConnell EE, Anderson R et al. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol: 1995; 7 425 467
96. McConnell EK, Kamstrup O, Musselman R et al. Chronic inhalation study of size-separated rock and slag wool insulation fibers in Fischer 344/N rats. Inhal Toxicol: 1994; 6 571 614
97. Pott F, Friedrichs KH, Huth F. Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their interpretation with regard to the carcinogenesis in humans. Zentralbl Bakteriol Orig B: 1976; 162 467 505
98. Pott F, Schlipköter HW, Ziem U et al. New results from implantation experiments with mineral fibres. In: WHO Biological effects of man-made mineral fibres Proceedings of a WHO/IARC Conference 1984. Copenhagen Regional Office for Europe: 1984; 286 302
99. Pott F, Roller M, Ziem U et al. Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. In: Bignon J, Peto J, Saracci R. eds. Non-occupational exposure to mineral fibres. Lyon International Agency for Research on Cancer: 1989; 173 179
100. Pott F, Bellmann B, Muhle H et al. Intraperitoneal injection studies for the evaluation of the carcinogenicity of fibrous phyllosilicates. In: Bignon J. ed. Health related effects of phyllosilicates (NATO ASI Series). Berlin Springer: 1990; 319 329
101. Roller M, Pott F, Kamino K et al. Results of current intraperitoneal carcinogenicity studies with mineral and vitreous fibres. Exp Toxicol Pathol: 1996; 48 3 12 (Pubitemid 26049183)
102. Roller M, Pott F, Kamino K et al. Dose-response relationship of fibrous dusts in intraperitoneal studies. Environ Health Perspect: 1997; 105 1253 1256
103. Bhattacharya K, Dopp E, Kakkar P et al. Biomarkers in risk assessment of asbestos exposure. Mutat Res: 2005; 579 6 21 (Pubitemid 41540129)
104. Poser I, Rahman Q, Lohani M et al. Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. Mutat Res: 2004; 559 19 27 (Pubitemid 38452914)
105. Schins RP. Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol: 2002; 14 57 78 (Pubitemid 34094360)
106. Speit G. Appropriate in vitro test conditions for genotoxicity testing of fibers. Inhal Toxicol: 2002; 14 79 90 (Pubitemid 34094361)
107. Baur X, Schneider J, Woitowitz H-J. Diagnostik und Begutachtung asbestbedingter Berufskrankheiten. Dtsch Med Wochenschr: 2011; 136 2319 2324
108. Baur X, Wilken D. Antwort auf Leserbriefe zu X. Baur, D. Wilken. Auswirkungen der Asbestfaserstaub-Exposition auf die Lungenfunktion - ein systematisches Review. Pneumologie 2010; 64: 81-110 Pneumologie: 2010; 64 436 441
109. Müsken H. Leserbrief zu X. Baur, D. Wilken. Auswirkungen der Asbestfaserstaub-Exposition auf die Lungenfunktion - ein systematisches Review. Pneumologie 2010; 64: 81-110 Pneumologie: 2010; 64 433
110. Neumann V, Tannapfel A. Leserbrief zu X. Baur, D. Wilken. Auswirkungen der Asbestfaserstaub-Exposition auf die Lungenfunktion - ein systematisches Review. Pneumologie 2010; 64: 81-110 Pneumologie: 2010; 64 430 432
111. Beyer V. Stellungnahme des Deutschen Gewerkschaftsbundes (DGB). Falkensteiner Tage 2010 Kolloquium zur Begutachtung asbestbedingter Berufskrankheiten Berlin DGUV: 2011; 125 127
112. Henderson D, Rantanen J, Barnhart S et al. Asbestos, asbestosis and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health: 1997; 23 311 316 (Pubitemid 27429697)